Diabetes drug metformin may boost chemo for ovarian cancer
NCT ID NCT02122185
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase II trial tested whether adding metformin, a common diabetes drug, to standard chemotherapy could help control advanced ovarian, fallopian tube, or primary peritoneal cancer. 111 participants received either metformin or a placebo alongside chemotherapy, followed by maintenance therapy. The goal was to see if metformin could delay cancer progression by making tumor cells more sensitive to chemo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
metformin hydrochloride (Glucophage)
What this could lead to
If successful, this could point toward a way to make chemotherapy more effective for advanced ovarian cancer, potentially delaying disease progression.
What could go wrong
This is a phase II trial with only 111 participants, so results are preliminary. Metformin may not improve outcomes, and side effects from chemotherapy remain a risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN ENDOMETRIOID ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Decatur Memorial Hospital
Decatur, Illinois, 62526, United States
-
Ingalls Memorial Hospital
Harvey, Illinois, 60426, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mitchell Cancer Institute - University of South Alabama
Mobile, Alabama, 36604, United States
-
NCH Medical Group- Northwest Community Hospital
Arlington Heights, Illinois, 60005, United States
-
NorthShore University HealthSystem
Evanston, Illinois, 60201, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
University of Alabama
Birmingham, Alabama, 35233, United States
-
University of Chicago
Chicago, Illinois, 60637, United States